Related references
Note: Only part of the references are listed.Immunomodulation by Mesenchymal Stem Cells (MSCs): Mechanisms of Action of Living, Apoptotic, and Dead MSCs
Andreas Robert Rudolf Weiss et al.
FRONTIERS IN IMMUNOLOGY (2019)
Positive correlation between fasting plasma glucagon and serum C-peptide in Japanese patients with diabetes
Yoshiya Hosokawa et al.
HELIYON (2019)
C-Peptide Decline in Type 1 Diabetes Has Two Phases: An Initial Exponential Fall and a Subsequent Stable Phase
Beverley M. Shields et al.
DIABETES CARE (2018)
Vitamin D and diabetes mellitus: Causal or casual association?
M. Grammatiki et al.
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS (2017)
Insulin-secreting adipose-derived mesenchymal stromal cells with bone marrow-derived hematopoietic stem cells from autologous and allogenic sources for type 1 diabetes mellitus
Umang G. Thakkar et al.
CYTOTHERAPY (2015)
Preserved β-Cell Function in Type 1 Diabetes by Mesenchymal Stromal Cells
Per-Ola Carlsson et al.
DIABETES (2015)
Nutrition Therapy Recommendations for the Management of Adults With Diabetes
Alison B. Evert et al.
DIABETES CARE (2014)
Autografting of bone marrow mesenchymal stem cells alleviates streptozotocin-induced diabetes in miniature pigs: Real-time tracing with MRI in vivo
Kuanxiao Tang et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2014)
Hyperglycaemia is associated with impaired pulsatile insulin secretion: effect of basal insulin therapy
J. J. Meier et al.
DIABETES OBESITY & METABOLISM (2013)
Initiating type I diabetes: new suspects in the lineup
Remi J. Creusot
NATURE MEDICINE (2013)
Immune therapy in type 1 diabetes mellitus
Ake Lernmark et al.
NATURE REVIEWS ENDOCRINOLOGY (2013)
Stem Cell Therapy to Cure Type 1 Diabetes: From Hype to Hope
Preeti Chhabra et al.
STEM CELLS TRANSLATIONAL MEDICINE (2013)
Effect of Cholecalciferol as Adjunctive Therapy With Insulin on Protective Immunologic Profile and Decline of Residual β-Cell Function in New-Onset Type 1 Diabetes Mellitus
Mônica A. L. Gabbay et al.
ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE (2012)
Fall in C-Peptide During First 2 Years From Diagnosis Evidence of at Least Two Distinct Phases From Composite Type 1 Diabetes Trial Net Data
Carla J. Greenbaum et al.
DIABETES (2012)
The Pathogenesis and Natural History of Type 1 Diabetes
Mark A. Atkinson
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)
Making progress: preserving beta cells in type 1 diabetes
Mary Pat Gallagher et al.
YEAR IN DIABETES AND OBESITY (2011)
Stem cell transplantation for autoimmune diseases
Thomas Huegle et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2010)
An alternative method for the isolation of mesenchymal stromal cells derived from lipoaspirate samples
Leandra S. Baptista et al.
CYTOTHERAPY (2009)
C-Peptide Levels and Insulin Independence Following Autologous Nonmyeloablative Hematopoietic Stem Cell Transplantation in Newly Diagnosed Type 1 Diabetes Mellitus
Carlos E. B. Couri et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Immunomodulation by mesenchymal stem cells - A potential therapeutic strategy for type 1 diabetes
Reza Abdi et al.
DIABETES (2008)
Homing and engraftment of progenitor cells: A prerequisite for cell therapy
Emmanouil Chavakis et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2008)
Environmental triggers and determinants of type 1 diabetes
M Knip et al.
DIABETES (2005)
Natural history of type 1 diabetes
P Achenbach et al.
DIABETES (2005)
1,25-dihydroxyvitamin D3 modulates expression of chemokines and cytokines in pancreatic islets: Implications for prevention of diabetes in nonobese diabetic mice
CA Gysemans et al.
ENDOCRINOLOGY (2005)
A 1α,25-dihydroxyvitamin D3 analog enhances regulatory T-cells and arrests autoimmune diabetes in NOD mice
S Gregori et al.
DIABETES (2002)
Intake of vitamin D and risk of type 1 diabetes:: a birth-cohort study
E Hyppönen et al.
LANCET (2001)
Share Paper
